Good morning lads,
My god damned book is here. Be sure to toast it and leave a 5 star review into the Amazon ecosystem. I am exploring options to create a paperback and leatherbound version for those with rich libraries. In the meantime, the Kindle version will have to suffice.
Spain is down more than 1%. Chaos theory says Catalonions will break away from them, causing a civil war, at which time the EU will send shock troops in to restore order.
Gold is strong again, higher by 0.7% and WTI is +1%. Bitcoin is 4,800. I think I made a bet with someone that I’d cut off my genitalia should it go to 5,000. I don’t know why I always use my testicles in bets. There is really no upside to this way of thinking.
Nasdaq futures are +13. You can’t stop the fire.
Here are some notable movers in the pre-market, per Briefing.
UAL +4.3%, (provides Q3 investor update; raised its Q3 pre-tax margin guidance and updated other metrics)
WMT +2.3%, (reaffirms FY18 guidance; sees FY19 EPS +5% with sales up at or above 3%; adds to share buyback)
REVG +1.1%
USEG +25.8% (sale of certain non-operated Williston Basin assets; received $2.0 million in cash)
PFE +1% (reviewing strategic alternatives for its Consumer Healthcare business)
HON +0.7% (announces planned comprehensive portfolio review)
KALV +75.4% (enters collaboration agreement with Merck (MRK); Merck to pay $37 mln upfront payment, additionally take 9.9% stake through private placement at $8.50/share)
ANAB +57.1% (announces positive proof-of-concept data for ANB020)
PSDV +12.3% (enters strategic collaboration agreement with Nicox to develop sustained release drug to lower intraocular pressure in patients with glaucoma)
REPH +10.6% (presents clinical efficacy data from its Phase III study evaluating intravenous (IV) meloxicam 30mg)
OVID +8.2% (receives orphan drug designation from the U.S. FDA for OV101)
ICHR +5.9% (entered into ‘substantial’ agreement to produce liquid delivery systems for one of its key customers)
NVDA +4.2% (announces new Drive PX Pegasus AI hardware that enables fully autonomous (level 5) driving – TechCrunch)
ATRS +4% (enters into a definitive asset purchase agreement to sell the worldwide rights, including certain fixed assets, for the ZOMAJET )
ALDX +2.6% (announces new clinical data for ADX-102 from recently completed Phase 2 clinical trials of dry eye disease and allergic conjunctivitis), CLVS +1.8% ( submitted sNDA to the FDA for rucaparib as maintenance treatment of patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in a complete or partial response to platinum-based chemotherapy)
DXC +1.2% (to acquire Logicalis SMC)
REVG +1.1% (announces an underwritten public offering of 10,000,000 shares of common stock by certain selling stockholders)
AGN +1% (FDA has accepted the NDA for ulipristal acetate)
ABEO +4% (initiated with a Buy at Citigroup)
PANW +2.8% (upgraded to Overweight from Equal-Weight at Morgan Stanley)
RBS +2.5% (upgraded to Neutral from Underperform at Credit Suisse; upgraded to Neutral from Sell at Citigroup)
RIG +1.6% (initiated with Buy ratings at Deutsche Bank)
TSM +1.5% (upgraded to Overweight from Neutral at JP Morgan)
DVN +1.4% (upgraded to Buy at Jefferies)
DO +1.3% (upgraded to Neutral from Sell at FBR & Co)
TSLA +1.2% (target raised to $379 from $317 at Morgan Stanley)
LYG +0.8% (upgraded to Outperform from Neutral at Credit Suisse)
CXO +0.8% (upgraded to Buy at Jefferies)
CAT +0.7% (target raised to $158 at Goldman – new street high)
CLB +0.7% (initiated with Buy ratings at Deutsche Bank)
HAL +0.5% (initiated with Buy ratings at Deutsche Bank)
How about them semis?
If you enjoy the content at iBankCoin, please follow us on Twitter
Title listed in Amazon is not the same one as is on the book’s cover.
In a Car Made FROM Dynamite, Racing Towards the Sun vs. In a Car Made OF Dynam……
That will be corrected. Small oversight.